0001209191-15-029323.txt : 20150325
0001209191-15-029323.hdr.sgml : 20150325
20150325193417
ACCESSION NUMBER: 0001209191-15-029323
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20150319
FILED AS OF DATE: 20150325
DATE AS OF CHANGE: 20150325
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: CORCEPT THERAPEUTICS INC
CENTRAL INDEX KEY: 0001088856
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 770487658
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 149 COMMONWEALTH DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
BUSINESS PHONE: 650.688.8803
MAIL ADDRESS:
STREET 1: 149 COMMONWEALTH DRIVE
CITY: MENLO PARK
STATE: CA
ZIP: 94025
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: COOK JOSEPH C JR
CENTRAL INDEX KEY: 0001024003
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
STATE OF INCORPORATION: CA
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-50679
FILM NUMBER: 15725906
MAIL ADDRESS:
STREET 1: MOUNTAIN GROUP CAPITAL, LLC
STREET 2: 1600 DIVISION STREET, SUITE 580
CITY: NASHVILLE
STATE: TN
ZIP: 37203
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2015-03-19
0
0001088856
CORCEPT THERAPEUTICS INC
CORT
0001024003
COOK JOSEPH C JR
C/O CORCEPT THERAPEUTICS INCORPORATED
149 COMMONWEALTH DRIVE
MENLO PARK
CA
94025
1
0
0
0
Common Stock
2015-03-19
4
X
0
145480
2.77
A
2186306
D
Common Stock
2015-03-19
4
S
0
77200
5.22
D
2109106
D
Common Stock
2015-03-19
4
X
0
14402
2.77
A
249164
I
See footnotes (2) and (3)
Common stock
2015-03-19
4
S
0
7643
5.22
D
241521
I
See footnotes (2) and (3)
Common stock
2015-03-19
4
X
0
13995
2.77
A
363995
I
See footnotes (4) and (5)
Common stock
2015-03-19
4
S
0
7427
5.22
D
356568
I
See footnotes (4) and (5)
Warrant (Right to Buy)
2.77
2015-03-19
4
X
0
31570
0.00
D
2009-02-06
2015-03-24
Common Stock
31570
88261
D
Warrant (Right to Buy)
2.77
2015-03-19
4
X
0
88261
0.00
D
2008-03-25
2015-03-24
Common Stock
88261
0
D
Warrant (Right to Buy)
2.77
2015-03-19
4
X
0
25649
0.00
D
2009-02-06
2015-03-24
Common Stock
25649
0
D
Warrant (Right to Buy)
2.77
2015-03-19
4
X
0
14402
0.00
D
2009-02-06
2015-03-24
Common Stock
14402
0
I
See footnote (2)
Warrant (Right to Buy)
2.77
2015-03-19
4
X
0
13995
0.00
D
2009-02-06
2015-03-24
Common Sotck
13995
0
I
See footnote (4)
On March 19, 2015, the reporting person exercised warrants to purchase 145,480 shares of the Issuer's common stock for an exercise price of $2.77 per share. The reporting person paid the exercise prices on a cashless basis, resulting in the Issuer's withholding of 77,200 of such shares to pay the exercise price and issuing the remaining 68,280 shares to the reporting person.
On March 19, 2015, Farview Management, Co. L.P. (Farview) exercised a warrant to purchase 14,402 shares of the Issuer's common stock for an exercise price of $2.77 per share. Farview paid the exercise price on a cashless basis, resulting in the Issuer withholding 7,643 of such shares to pay the exercise price and issuing to Farview the remaining 6,759 shares.
Reflects transactions and holdings of shares of common stock of the Issuer held of records by Farview Management, Co. L.P., of which the reporting person is a general partner.
On March 19, 2015, the Judith E. and Joseph C. Cook, Jr. Foundation, Inc., or Cook Foundation, exercised a warrant to purchase 13,995 shares of the Issuer's common stock for an exercise price of $2.77 per share. The Cook Foundation paid the exercise price on a cashless basis, resulting in the Issuer's withholding 7,427 of such shares to pay the exercise price and issuing to the Cook Foundation the remaining 6,568 shares. Mr. Cook and Judith E. Cook may be deemed to have shared voting and investment power over the shares held by the Cook Foundation. Each of these individuals disclaims beneficial ownership of all such shares, except to the extent of his or her pecuniary interest therein.
Reflects transactions and holdings of shares of common stock of the Issuer held of record by the Cook Foundation.
/s/ Joseph K. Belanoff, CEO of Corcept Therapeutics Incorporated attorney-in-fact
2015-03-25